Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Monopar Therapeutics (MNPR) Shares Issued (2017 - 2020)

Monopar Therapeutics (MNPR) has disclosed Shares Issued for 2 consecutive years, with -$1.4 million as the latest value for Q3 2020.

  • Quarterly Shares Issued changed N/A to -$1.4 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Jun 2020, changed N/A year-over-year, with the annual reading at $565171.0 for FY2025, 672722.62% up from the prior year.
  • Shares Issued hit -$1.4 million in Q3 2020 for Monopar Therapeutics, down from $1.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.7 million in Q3 2017 to a low of -$1.4 million in Q3 2020.